Epigenetic control of E-cadherin (CDH1) by CpG methylation in metastasising laryngeal cancer

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 501-503

  Azarschab, Pia ^a   Stembalska, Agnieszka ^c   Loncar, Mirela Baus ^a   Pfister, Markus ^b   Sasiadek, Maria M ^c   Blin, Nikolaus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Adhesion molecules; Gene inactivation; Metastasis; Methylation

Indexed keywords

CADHERIN; PRIMER DNA;

ADENOCARCINOMA; ARTICLE; CHEMISTRY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC SCREENING; GENETICS; HUMAN; LARYNX TUMOR; METABOLISM; METASTASIS; PATHOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION;

ADENOCARCINOMA; CADHERINS; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC SCREENING; HUMANS; LARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS);

EID: 0037810703     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.501     Document Type: Article

References (30)

1. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1251: 1451-1455, 1999.
2. Takeichi M: Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5: 806-811, 1993.
3. Berx G, Cleton-Jansen AM, Nollet F, De Leeuw WJ, van De Vijver M, Cornelisse C and van Roy F: E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBOJ 14: 6107-6115, 1995. (Pubitemid 26007298)
4. Kemler R: From Cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9: 317-321, 1993.
5. Birchmeier W: E-cadherin as a tumor (invasion) suppressor gene. Bioessays 17: 97-99, 1995.
6. Dorudi S, Sheffield JP, Poulsom R, Northover JM and Hart IR: E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am Pathol 142: 981-986, 1993. (Pubitemid 24060573)
7. Pignatelli M, Ansari TW, Gunter P, Liu D, Hirano S, Takeichi M, Kloppel G and Lemoine NR: Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol 174: 243-248, 1994.
8. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W and Hommel G: Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69: 184-189, 1996. (Pubitemid 26233296)
9. Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G and Sobrinho-Simoes M: E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 79: 459-465, 1999. (Pubitemid 29190435)
10. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199, 1995.
11. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E and Birchmeier W: Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11: 475-484, 1995.
12. Berx G, Becker KF, Hofler H and van Roy F: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 12: 226-237, 1998. (Pubitemid 28418891)
13. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Hinoda Y and Imai K: Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83: 309-313, 1999. (Pubitemid 29455752)
14. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF and Minna JD: Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249-255, 2001. (Pubitemid 32095725)
15. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K and Birchmeier W: E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 51: 6328-6337, 1991.
16. Nakayama S, Sasaki A, Mese H, Alcalde RE, Tsuji T and Matsumura T: The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinoma. Int J Cancer 93: 667-673, 2001. (Pubitemid 32695114)
17. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996. (Pubitemid 26296693)
18. Knudson AG: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823, 1971.
19. Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M and Porschen R: Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 58: 3942-3945, 1998. (Pubitemid 28405652)
20. Carvalho R, Kayademir T, Soares P, Canedo P, Sousa S, Oliveira C, Leistenschneider P, Carneiro F, Gött P, Blin N, Seruca R and Machado JC: LOH and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab Invest 82: 1319-1326, 2002.
21. Vessey CJ, Wilding J, Folarin N, Hirano S, Takeichi M, Soutter P, Stamp GW and Pignatelli M: Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol 176: 151-159, 1995.
22. Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I and Hart IR: Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 92: 404-408, 2001. (Pubitemid 32249718)
23. Matsumura T, Makino R and Mitamura K: Frequent downregulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 7: 594-599, 2001. (Pubitemid 32707984)
24. Azarschab P, Porschen R, Gregor M, Blin N and Holzmann K: Epigenetic control of E-cadherin (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Genes Chromos Cancer 35: 121-126, 2002. (Pubitemid 34919968)
25. Nigam AK, Savage FJ, Boulos PB, Stamp GW, Liu D and Pignatelli M: Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 68: 507-514, 1993. (Pubitemid 23258453)
26. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F and Sobrinho-Simoes M: E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene 20: 1525-1528, 2001. (Pubitemid 32291203)
27. Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T and Meltzer SJ: E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569-573, 2000. (Pubitemid 30212319)
28. Toyooka S, Toyooka KO, Harada K, Miyajima K, Makarla P, Sathyanarayana UG, Yin J, Sato F, Shivapurkar N, Meltzer SJ and Gazdar AF: Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62: 3382-3386, 2002. (Pubitemid 34651383)
29. Rodrigo JP, Dominguez F, Alvarez C, Manrique C, Herrero A and Suarez C: Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 38: 1041-1043, 2002.
30. Davies MA, Kim SJ, Parikh NU, Dong Z, Bucana SD and Gallick GE: Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin Cancer Res 8: 1904-1914, 2002. (Pubitemid 34633753)